The global biotechnology market value is estimated to reach USD 775.20 billion by 2024. The worldwide market is expected to register a CAGR of 9.9% during the forecast period (2018 – 2024). The growth of biotechnology market value is increasing rapidly.

 Market value in America: 
North America dominates the market size due there fast technological applications. It is estimated more than 250 biotechnology health care products and vaccines have been made for the patients, among all many of these are useful for previously untreatable diseases.13.3 million farmers around the globe use agricultural biotechnology to increase yields, prevent damage from insects and pests and reduce damage done on environment due to farming. Around 50 bio-refineries are being built across North America to test and refine technologies to produce biofuels and chemicals from renewable biomass, which can help reduce greenhouse gas emissions.

Market value in Europe:
Biotechnology sector is considered of strategic importance to the European economy, with around 25 billion U. S. dollars of revenue and 72 thousand employees. Over the last few years, the biotechnology became one of the most productive industries in the European Union, with almost 80 thousand patent applications registered in 2014. However, because of the high research and development costs may grow at a CAGR of 6.4% from 2018 to reach $1,084.3 million by 2024 many European biotechnology companies must partner with larger firms to complete the development of their products and patents.

Market value in Asia-Pacific:
Biotechnology in Asia-Pacific industry profile gives great qualitative and quantitative summary information. The biotechnology industry consists of the research of development, manufacturing, and industry of products produced from advanced biotechnology research. The Asia-Pacific biotechnology firm had total revenues of $77.4billion in 2014, registering a compound annual growth rate (CAGR) of 6.8% from 2010 and 2014.The medical/healthcare segment was the industry’s most profitable in 2014, with total revenues of $40.1bn, equivalent to 51.8% of the industry's overall value. The performance of the industry is forecast to reduced, with CAGR of 5.1% for the five-year period 2014 - 2019, which is expected to take the industry to a value of $99.1bn by the end of 2019.